Search research articles
Contact Us
Filters
Showing results (501-510 of 618) with videos related to
Page
of 62
Sort By:
Plant Biotechnology Journal
|
November 18, 2022
Sequencing of Camelina neglecta, a diploid progenitor of the hexaploid oilseed Camelina sativa
Raju Chaudhary, Chu Shin Koh, Sampath Perumal, et al.
Drug and Alcohol Dependence
|
May 22, 2024
Treatment with dextroamphetamine decreases the reacquisition of cocaine self-administration: Consistency across social contexts
Mark A Smith, Alexandra N Johansen, Hannah S H Cha, et al.
Journal of Neuropathology and Experimental Neurology
|
June 14, 2011
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies
Jeremy G Stone, Sandra L Siedlak, Massimo Tabaton, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
November 30, 2002
Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response
George Perry, Marta A Taddeo, Akihiko Nunomura, et al.
Acta Neuropathologica
|
April 5, 2003
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
Osamu Ogawa, Xiongwei Zhu, Hyoung-Gon Lee, et al.
Free Radical Biology & Medicine
|
April 10, 2003
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants
Gerald Veurink, Dan Liu, Kevin Taddei, et al.
Age (Dordrecht, Netherlands)
|
May 9, 2009
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes
Na-Hye Myung, Xiongwei Zhu, Inna I Kruman, et al.
Aging Cell
|
February 18, 2004
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients
Hossein A Ghanbari, Kasra Ghanbari, Peggy L R Harris, et al.
Biological Psychiatry
|
December 5, 2012
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression
Carlos A Zarate, Daniel Mathews, Lobna Ibrahim, et al.
Journal of Clinical Psychopharmacology
|
December 11, 2014
AZD6280, a novel partial γ-aminobutyric acid A receptor modulator, demonstrates a pharmacodynamically selective effect profile in healthy male volunteers
Xia Chen, Gabriel Jacobs, Marieke L de Kam, et al.
Page
of 62
Search research articles
Search
Showing results (501-510 of 618) with videos related to
Sort By:
Page
of 62
Plant Biotechnology Journal
|
November 18, 2022
Sequencing of Camelina neglecta, a diploid progenitor of the hexaploid oilseed Camelina sativa
Raju Chaudhary, Chu Shin Koh, Sampath Perumal, et al.
Drug and Alcohol Dependence
|
May 22, 2024
Treatment with dextroamphetamine decreases the reacquisition of cocaine self-administration: Consistency across social contexts
Mark A Smith, Alexandra N Johansen, Hannah S H Cha, et al.
Journal of Neuropathology and Experimental Neurology
|
June 14, 2011
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies
Jeremy G Stone, Sandra L Siedlak, Massimo Tabaton, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
November 30, 2002
Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response
George Perry, Marta A Taddeo, Akihiko Nunomura, et al.
Acta Neuropathologica
|
April 5, 2003
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
Osamu Ogawa, Xiongwei Zhu, Hyoung-Gon Lee, et al.
Free Radical Biology & Medicine
|
April 10, 2003
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants
Gerald Veurink, Dan Liu, Kevin Taddei, et al.
Age (Dordrecht, Netherlands)
|
May 9, 2009
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes
Na-Hye Myung, Xiongwei Zhu, Inna I Kruman, et al.
Aging Cell
|
February 18, 2004
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients
Hossein A Ghanbari, Kasra Ghanbari, Peggy L R Harris, et al.
Biological Psychiatry
|
December 5, 2012
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression
Carlos A Zarate, Daniel Mathews, Lobna Ibrahim, et al.
Journal of Clinical Psychopharmacology
|
December 11, 2014
AZD6280, a novel partial γ-aminobutyric acid A receptor modulator, demonstrates a pharmacodynamically selective effect profile in healthy male volunteers
Xia Chen, Gabriel Jacobs, Marieke L de Kam, et al.
Page
of 62